Using chromatin accessibility analysis, we investigated the epigenetic landscape in 23 breast cancer cell lines, including 2 ER+/HER2−, 3 ER+/HER2+, 3 HER2+, and 15 TNBC lines (Supplementary Table 1). This evidence concerns the gene ERBB2 and breast carcinoma.